Any 0 3 0 3 O
concurrent 4 14 4 14 O
severe 15 21 15 21 O
and/or 22 28 22 28 O
uncontrolled 29 41 29 41 O
medical 42 49 42 49 O
conditions 50 60 50 60 O
that 61 65 61 65 O
could 66 71 66 71 O
increase 72 80 72 80 O
the 81 84 81 84 O
patient 85 92 85 92 O
's 92 94 92 94 O
risk 95 99 95 99 O
for 100 103 100 103 O
toxicity 104 112 104 112 O
while 113 118 113 118 O
in 119 121 119 121 O
the 122 125 122 125 O
study 126 131 126 131 O
or 132 134 132 134 O
that 135 139 135 139 O
could 140 145 140 145 O
confound 146 154 146 154 O
discrimination 155 169 155 169 O
between 170 177 170 177 O
disease- 178 186 178 186 O
and 187 190 187 190 O
study 191 196 191 196 O
treatment 197 206 197 206 B-treatment
- 206 207 206 207 O
related 207 214 207 214 O
toxicities 215 225 215 225 O

At 0 2 226 228 O
least 3 8 229 234 O
2 9 10 235 236 B-lower_bound
weeks 11 16 237 242 I-lower_bound
from 17 21 243 247 O
prior 22 27 248 253 B-treatment
MF 28 30 254 256 I-treatment
- 30 31 256 257 I-treatment
directed 31 39 257 265 I-treatment
treatment 40 49 266 275 I-treatment
( 50 51 276 277 O
till 51 55 277 281 O
the 56 59 282 285 O
start 60 65 286 291 O
of 66 68 292 294 O
study 69 74 295 300 B-treatment
drug 75 79 301 305 I-treatment
) 79 80 305 306 O

Eastern 0 7 307 314 B-clinical_variable
Cooperative 8 19 315 326 I-clinical_variable
Oncology 20 28 327 335 I-clinical_variable
Group 29 34 336 341 I-clinical_variable
( 35 36 342 343 I-clinical_variable
ECOG 36 40 343 347 I-clinical_variable
) 40 41 347 348 I-clinical_variable
performance 42 53 349 360 I-clinical_variable
status 54 60 361 367 I-clinical_variable
0 61 62 368 369 B-lower_bound
- 62 63 369 370 O
2 63 64 370 371 B-upper_bound

Impaired 0 8 372 380 B-chronic_disease
cardiac 9 16 381 388 I-chronic_disease
function 17 25 389 397 I-chronic_disease
or 26 28 398 400 O
clinically 29 39 401 411 O
significant 40 51 412 423 O
cardiac 52 59 424 431 B-chronic_disease
diseases 60 68 432 440 I-chronic_disease
, 68 69 440 441 O
including 70 79 442 451 O
any 80 83 452 455 O
of 84 86 456 458 O
the 87 90 459 462 O
following 91 100 463 472 O
: 100 101 472 473 O
history 102 109 474 481 O
or 110 112 482 484 O
presence 113 121 485 493 O
of 122 124 494 496 O
ventricular 125 136 497 508 B-chronic_disease
tachyarrhythmia 137 152 509 524 I-chronic_disease
; 152 153 524 525 O
presence 154 162 526 534 O
of 163 165 535 537 O
unstable 166 174 538 546 O
atrial 175 181 547 553 B-chronic_disease
fibrillation 182 194 554 566 I-chronic_disease
( 195 196 567 568 O
ventricular 196 207 568 579 B-clinical_variable
response 208 216 580 588 I-clinical_variable
> 217 218 589 590 O
100 219 222 591 594 B-lower_bound
beats 223 228 595 600 I-lower_bound
per 229 232 601 604 I-lower_bound
minute 233 239 605 611 I-lower_bound
[ 240 241 612 613 I-lower_bound
bpm 241 244 613 616 I-lower_bound
] 244 245 616 617 I-lower_bound
) 245 246 617 618 O
; 246 247 618 619 O
patients 248 256 620 628 O
with 257 261 629 633 O
stable 262 268 634 640 O
atrial 269 275 641 647 O
fibrillation 276 288 648 660 O
are 289 292 661 664 O
eligible 293 301 665 673 O
, 301 302 673 674 O
provided 303 311 675 683 O
they 312 316 684 688 O
do 317 319 689 691 O
not 320 323 692 695 O
meet 324 328 696 700 O
any 329 332 701 704 O
of 333 335 705 707 O
the 336 339 708 711 O
other 340 345 712 717 O
cardiac 346 353 718 725 O
exclusion 354 363 726 735 O
criteria 364 372 736 744 O
; 372 373 744 745 O
clinically 374 384 746 756 O
significant 385 396 757 768 O
resting 397 404 769 776 O
bradycardia 405 416 777 788 B-clinical_variable
( 417 418 789 790 O
< 418 419 790 791 O
50 420 422 792 794 B-upper_bound
bpm 423 426 795 798 I-upper_bound
) 426 427 798 799 O
; 427 428 799 800 O
angina 429 435 801 807 B-chronic_disease
pectoris 436 444 808 816 I-chronic_disease
or 445 447 817 819 O
acute 448 453 820 825 O
myocardial 454 464 826 836 B-chronic_disease
infarction 465 475 837 847 I-chronic_disease
= 476 477 848 849 O
< 477 478 849 850 O
3 479 480 851 852 B-upper_bound
months 481 487 853 859 I-upper_bound
prior 488 493 860 865 I-upper_bound
to 494 496 866 868 O
starting 497 505 869 877 O
study 506 511 878 883 O
drug 512 516 884 888 O
; 516 517 888 889 O
other 518 523 890 895 O
clinically 524 534 896 906 O
significant 535 546 907 918 O
heart 547 552 919 924 B-chronic_disease
disease 553 560 925 932 I-chronic_disease
( 561 562 933 934 O
e.g. 562 566 934 938 O
, 566 567 938 939 O
symptomatic 568 579 940 951 O
congestive 580 590 952 962 B-chronic_disease
heart 591 596 963 968 I-chronic_disease
failure 597 604 969 976 I-chronic_disease
; 604 605 976 977 O
uncontrolled 606 618 978 990 O
arrhythmia 619 629 991 1001 O
or 630 632 1002 1004 O
hypertension 633 645 1005 1017 B-chronic_disease
; 645 646 1017 1018 O
history 647 654 1019 1026 O
of 655 657 1027 1029 O
labile 658 664 1030 1036 B-chronic_disease
hypertension 665 677 1037 1049 I-chronic_disease
or 678 680 1050 1052 O
poor 681 685 1053 1057 O
compliance 686 696 1058 1068 O
with 697 701 1069 1073 O
an 702 704 1074 1076 O
antihypertensive 705 721 1077 1093 B-treatment
regimen 722 729 1094 1101 I-treatment
) 729 730 1101 1102 O

Must 0 4 1103 1107 O
be 5 7 1108 1110 O
diagnosed 8 17 1111 1120 O
with 18 22 1121 1125 O
treatment 23 32 1126 1135 B-treatment
requiring 33 42 1136 1145 O
PMF 43 46 1146 1149 B-chronic_disease
or 47 49 1150 1152 O
post 50 54 1153 1157 O
ET 55 57 1158 1160 O
/ 57 58 1160 1161 O
PV 58 60 1161 1163 O
MF 61 63 1164 1166 O
with 64 68 1167 1171 O
intermediate-1 69 83 1172 1186 O
, 83 84 1186 1187 O
intermediate 85 97 1188 1200 O
-2 98 100 1201 1203 O
or 101 103 1204 1206 O
high 104 108 1207 1211 O
risk 109 113 1212 1216 O
disease 114 121 1217 1224 O
according 122 131 1225 1234 O
to 132 134 1235 1237 O
the 135 138 1238 1241 O
International 139 152 1242 1255 O
Working 153 160 1256 1263 O
Group 161 166 1264 1269 O
( 167 168 1270 1271 O
IWG 168 171 1271 1274 O
) 171 172 1274 1275 O
prognostic 173 183 1276 1286 O
scoring 184 191 1287 1294 O
system 192 198 1295 1301 O
, 198 199 1301 1302 O
or 200 202 1303 1305 O
if 203 205 1306 1308 O
with 206 210 1309 1313 O
low 211 214 1314 1317 O
risk 215 219 1318 1322 O
disease 220 227 1323 1330 O
then 228 232 1331 1335 O
with 233 237 1336 1340 O
symptomatic 238 249 1341 1352 B-clinical_variable
splenomegaly 250 262 1353 1365 I-clinical_variable
that 263 267 1366 1370 O
is 268 270 1371 1373 O
> 271 272 1374 1375 O
= 272 273 1375 1376 O
5 274 275 1377 1378 B-lower_bound
cm 276 278 1379 1381 I-lower_bound
below 279 284 1382 1387 I-lower_bound
left 285 289 1388 1392 O
costal 290 296 1393 1399 O
margin 297 303 1400 1406 O
by 304 306 1407 1409 O
physical 307 315 1410 1418 O
exam 316 320 1419 1423 O

Patient 0 7 1424 1431 O
is 8 10 1432 1434 O
able 11 15 1435 1439 O
to 16 18 1440 1442 O
swallow 19 26 1443 1450 O
and 27 30 1451 1454 O
retain 31 37 1455 1461 O
oral 38 42 1462 1466 B-treatment
medication 43 53 1467 1477 I-treatment

Patients 0 8 1478 1486 O
who 9 12 1487 1490 O
are 13 16 1491 1494 O
currently 17 26 1495 1504 O
receiving 27 36 1505 1514 O
chronic 37 44 1515 1522 O
( 45 46 1523 1524 O
> 46 47 1524 1525 O
14 48 50 1526 1528 B-lower_bound
days 51 55 1529 1533 I-lower_bound
) 55 56 1533 1534 O
treatment 57 66 1535 1544 B-treatment
with 67 71 1545 1549 I-treatment
corticosteroids 72 87 1550 1565 I-treatment
at 88 90 1566 1568 O
a 91 92 1569 1570 O
dose 93 97 1571 1575 O
> 98 99 1576 1577 O
= 99 100 1577 1578 O
10 101 103 1579 1581 B-lower_bound
mg 104 106 1582 1584 I-lower_bound
of 107 109 1585 1587 O
prednisone 110 120 1588 1598 B-treatment
( 121 122 1599 1600 O
or 122 124 1600 1602 O
its 125 128 1603 1606 O
glucocorticoid 129 143 1607 1621 B-treatment
equivalent 144 154 1622 1632 O
) 154 155 1632 1633 O
per 156 159 1634 1637 O
day 160 163 1638 1641 O
, 163 164 1641 1642 O
or 165 167 1643 1645 O
any 168 171 1646 1649 O
other 172 177 1650 1655 O
chronic 178 185 1656 1663 B-treatment
immunosuppressive 186 203 1664 1681 I-treatment
treatment 204 213 1682 1691 I-treatment
that 214 218 1692 1696 O
can 219 222 1697 1700 O
not 222 225 1700 1703 O
be 226 228 1704 1706 O
discontinued 229 241 1707 1719 O
prior 242 247 1720 1725 O
to 248 250 1726 1728 O
starting 251 259 1729 1737 O
study 260 265 1738 1743 B-treatment
drug 266 270 1744 1748 I-treatment

Patients 0 8 1749 1757 O
who 9 12 1758 1761 O
are 13 16 1762 1765 O
currently 17 26 1766 1775 O
receiving 27 36 1776 1785 O
treatment 37 46 1786 1795 B-treatment
with 47 51 1796 1800 I-treatment
agents 52 58 1801 1807 I-treatment
that 59 63 1808 1812 I-treatment
are 64 67 1813 1816 I-treatment
metabolized 68 79 1817 1828 I-treatment
solely 80 86 1829 1835 I-treatment
through 87 94 1836 1843 I-treatment
cytochrome 95 105 1844 1854 I-treatment
P450 106 110 1855 1859 I-treatment
family 111 117 1860 1866 I-treatment
3 118 119 1867 1868 I-treatment
, 119 120 1868 1869 O
subfamily 121 130 1870 1879 B-treatment
A 131 132 1880 1881 I-treatment
, 132 133 1881 1882 O
polypeptide 134 145 1883 1894 B-treatment
4/5 146 149 1895 1898 I-treatment
( 150 151 1899 1900 I-treatment
CYP3A4/5 151 159 1900 1908 I-treatment
) 159 160 1908 1909 I-treatment
and 161 164 1910 1913 O
have 165 169 1914 1918 O
a 170 171 1919 1920 O
narrow 172 178 1921 1927 O
therapeutic 179 190 1928 1939 O
index 191 196 1940 1945 O
or 197 199 1946 1948 O
are 200 203 1949 1952 O
strong 204 210 1953 1959 O
cytochrome 211 221 1960 1970 O
P450 222 226 1971 1975 O
family 227 233 1976 1982 O
3 234 235 1983 1984 O
, 235 236 1984 1985 O
subfamily 237 246 1986 1995 B-treatment
C 247 248 1996 1997 I-treatment
, 248 249 1997 1998 O
polypeptide 250 261 1999 2010 B-treatment
8 262 263 2011 2012 I-treatment
( 264 265 2013 2014 I-treatment
CYP2C8 265 271 2014 2020 I-treatment
) 271 272 2020 2021 I-treatment
inhibitors 273 283 2022 2032 I-treatment
; 283 284 2032 2033 O
or 285 287 2034 2036 O
are 288 291 2037 2040 O
receiving 292 301 2041 2050 O
treatment 302 311 2051 2060 O
with 312 316 2061 2065 O
agents 317 323 2066 2072 O
that 324 328 2073 2077 O
carry 329 334 2078 2083 O
a 335 336 2084 2085 O
risk 337 341 2086 2090 O
for 342 345 2091 2094 O
QT 346 348 2095 2097 O
prolongation 349 361 2098 2110 O
and 362 365 2111 2114 O
are 366 369 2115 2118 O
CYP3A 370 375 2119 2124 O
substrates 376 386 2125 2135 O

Patients 0 8 2136 2144 O
who 9 12 2145 2148 O
are 13 16 2149 2152 O
not 17 20 2153 2156 O
candidates 21 31 2157 2167 O
for 32 35 2168 2171 O
, 35 36 2171 2172 O
intolerant 37 47 2173 2183 O
, 47 48 2183 2184 O
or 49 51 2185 2187 O
relapsed 52 60 2188 2196 O
/ 60 61 2196 2197 O
refractory 61 71 2197 2207 O
to 72 74 2208 2210 O
ruxolitinib 75 86 2211 2222 B-allergy_name

Patients 0 8 2223 2231 O
with 9 13 2232 2236 O
impairment 14 24 2237 2247 B-chronic_disease
of 25 27 2248 2250 I-chronic_disease
gastrointestinal 28 44 2251 2267 I-chronic_disease
( 45 46 2268 2269 I-chronic_disease
GI 46 48 2269 2271 I-chronic_disease
) 48 49 2271 2272 I-chronic_disease
function 50 58 2273 2281 O
or 59 61 2282 2284 O
GI 62 64 2285 2287 B-chronic_disease
disease 65 72 2288 2295 I-chronic_disease
that 73 77 2296 2300 O
may 78 81 2301 2304 O
significantly 82 95 2305 2318 O
alter 96 101 2319 2324 O
the 102 105 2325 2328 O
absorption 106 116 2329 2339 O
of 117 119 2340 2342 O
LCL161 120 126 2343 2349 B-treatment
as 127 129 2350 2352 O
per 130 133 2353 2356 O
physicians 134 144 2357 2367 O
opinion 145 152 2368 2375 O

Pregnant 0 8 2376 2384 B-pregnancy
or 9 11 2385 2387 O
breast 12 18 2388 2394 O
feeding 19 26 2395 2402 O
( 27 28 2403 2404 O
lactating 28 37 2404 2413 O
) 37 38 2413 2414 O
women 39 44 2415 2420 B-gender
, 44 45 2420 2421 O
where 46 51 2422 2427 O
pregnancy 52 61 2428 2437 B-pregnancy
is 62 64 2438 2440 O
defined 65 72 2441 2448 O
as 73 75 2449 2451 O
the 76 79 2452 2455 O
state 80 85 2456 2461 O
of 86 88 2462 2464 O
a 89 90 2465 2466 O
female 91 97 2467 2473 B-gender
after 98 103 2474 2479 O
conception 104 114 2480 2490 O
and 115 118 2491 2494 O
until 119 124 2495 2500 O
the 125 128 2501 2504 O
termination 129 140 2505 2516 O
of 141 143 2517 2519 O
gestation 144 153 2520 2529 O
, 153 154 2529 2530 O
confirmed 155 164 2531 2540 O
by 165 167 2541 2543 O
a 168 169 2544 2545 O
positive 170 178 2546 2554 O
beta 179 183 2555 2559 B-treatment
- 183 184 2559 2560 I-treatment
human 184 189 2560 2565 I-treatment
chorionic 190 199 2566 2575 I-treatment
gonadotropin 200 212 2576 2588 I-treatment
( 213 214 2589 2590 I-treatment
HCG 214 217 2590 2593 I-treatment
) 217 218 2593 2594 I-treatment
laboratory 219 229 2595 2605 O
test 230 234 2606 2610 O

Sexually 0 8 2611 2619 O
active 9 15 2620 2626 O
males 16 21 2627 2632 B-gender
must 22 26 2633 2637 O
use 27 30 2638 2641 B-contraception_consent
a 31 32 2642 2643 I-contraception_consent
condom 33 39 2644 2650 I-contraception_consent
during 40 46 2651 2657 I-contraception_consent
intercourse 47 58 2658 2669 I-contraception_consent
while 59 64 2670 2675 O
taking 65 71 2676 2682 O
the 72 75 2683 2686 O
drug 76 80 2687 2691 O
and 81 84 2692 2695 O
for 85 88 2696 2699 O
3 89 90 2700 2701 B-upper_bound
months 91 97 2702 2708 I-upper_bound
after 98 103 2709 2714 I-upper_bound
stopping 104 112 2715 2723 O
study 113 118 2724 2729 B-treatment
drug 119 123 2730 2734 I-treatment
and 124 127 2735 2738 O
should 128 134 2739 2745 O
not 135 138 2746 2749 O
father 139 145 2750 2756 O
a 146 147 2757 2758 O
child 148 153 2759 2764 O
in 154 156 2765 2767 O
this 157 161 2768 2772 O
period 162 168 2773 2779 O
; 168 169 2779 2780 O
a 170 171 2781 2782 O
condom 172 178 2783 2789 O
is 179 181 2790 2792 O
required 182 190 2793 2801 O
to 191 193 2802 2804 O
be 194 196 2805 2807 O
used 197 201 2808 2812 O
also 202 206 2813 2817 O
by 207 209 2818 2820 O
vasectomized 210 222 2821 2833 O
men 223 226 2834 2837 B-gender
in 227 229 2838 2840 O
order 230 235 2841 2846 O
to 236 238 2847 2849 O
prevent 239 246 2850 2857 O
delivery 247 255 2858 2866 O
of 256 258 2867 2869 O
the 259 262 2870 2873 O
drug 263 267 2874 2878 O
via 268 271 2879 2882 O
seminal 272 279 2883 2890 O
fluid 280 285 2891 2896 O

Treatment 0 9 2897 2906 B-treatment
- 9 10 2906 2907 O
related 10 17 2907 2914 O
toxicities 18 28 2915 2925 O
from 29 33 2926 2930 O
prior 34 39 2931 2936 B-treatment
therapies 40 49 2937 2946 I-treatment
must 50 54 2947 2951 O
have 55 59 2952 2956 O
resolved 60 68 2957 2965 O
to 69 71 2966 2968 O
grade 72 77 2969 2974 B-clinical_variable
= 78 79 2975 2976 O
< 79 80 2976 2977 O
1 81 82 2978 2979 B-upper_bound

Willing 0 7 2980 2987 O
and 8 11 2988 2991 O
able 12 16 2992 2996 O
to 17 19 2997 2999 O
comply 20 26 3000 3006 O
with 27 31 3007 3011 O
scheduled 32 41 3012 3021 O
visits 42 48 3022 3028 O
, 48 49 3028 3029 O
treatment 50 59 3030 3039 B-treatment
plan 60 64 3040 3044 O
and 65 68 3045 3048 O
laboratory 69 79 3049 3059 O
tests 80 85 3060 3065 O

